Portolan Capital Management - Q4 2020 holdings

$1.1 Billion is the total value of Portolan Capital Management's 164 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 39.6% .

 Value Shares↓ Weighting
QNST SellQUINSTREET, INC.$28,199,000
+16.9%
1,315,238
-13.6%
2.56%
-6.1%
AMZN SellAMAZON.COM, INC.$24,420,000
+2.3%
7,498
-1.1%
2.22%
-17.8%
DOMO SellDOMO, INC.$17,684,000
+66.0%
277,313
-0.2%
1.61%
+33.4%
CRMT SellAMERICAS CAR MART, INC.$17,357,000
-6.9%
158,017
-28.1%
1.58%
-25.2%
NAVI SellNAVIENT CORPORATION$16,129,000
-15.5%
1,642,486
-27.2%
1.47%
-32.1%
LPRO SellOPEN LENDING CORPORATION$14,196,000
-50.8%
406,067
-64.1%
1.29%
-60.5%
LPSN SellLIVEPERSON, INC.$14,089,000
+12.5%
226,397
-6.0%
1.28%
-9.6%
BAND SellBANDWIDTH, INC.$13,348,000
-38.7%
86,864
-30.4%
1.21%
-50.8%
OMF SellONEMAIN HOLDINGS, INC.$12,645,000
+29.7%
262,564
-15.8%
1.15%
+4.2%
CLDR SellCLOUDERA, INC.$11,689,000
-1.5%
840,335
-22.9%
1.06%
-20.9%
CROX SellCROCS, INC.$10,787,000
-17.4%
172,159
-43.7%
0.98%
-33.6%
GOOG SellALPHABET, INC.$10,352,000
+0.9%
5,909
-15.4%
0.94%
-18.9%
UPLD SellUPLAND SOFTWARE, INC.$10,118,000
-43.6%
220,481
-53.7%
0.92%
-54.7%
SHYF SellSHYFT GROUP, INC. (THE)$9,524,000
-19.4%
335,573
-46.4%
0.87%
-35.2%
HALO SellHALOZYME THERAPEUTICS, INC.$8,922,000
-16.4%
208,900
-48.5%
0.81%
-32.8%
CHRA SellCHARAH SOLUTIONS, INC.$8,548,000
-6.6%
2,978,524
-0.1%
0.78%
-24.9%
IAC SellIAC/INTERACTIVECORP.$8,188,000
+27.7%
43,245
-19.2%
0.74%
+2.6%
RH SellRH$7,892,000
+7.0%
17,635
-8.5%
0.72%
-14.0%
QLYS SellQUALYS, INC.$7,334,000
-11.4%
60,177
-28.8%
0.67%
-28.8%
PRTS SellCARPARTS.COM, INC.$7,171,000
+6.7%
578,792
-6.9%
0.65%
-14.2%
SKY SellSKYLINE CHAMPION CORPORATION$7,125,000
-17.4%
230,287
-28.5%
0.65%
-33.6%
BIO SellBIO-RAD LABORATORIES, INC.$7,065,000
-23.2%
12,119
-32.1%
0.64%
-38.4%
ECPG SellENCORE CAPITAL GROUP, INC.$7,023,000
-29.8%
180,305
-30.4%
0.64%
-43.6%
SONO SellSONOS, INC.$6,865,000
-7.7%
293,486
-40.1%
0.62%
-25.8%
PI SellIMPINJ, INC.$6,450,000
+42.7%
154,039
-10.2%
0.59%
+14.5%
MXL SellMAXLINEAR, INC.$6,114,000
+8.4%
160,092
-34.0%
0.56%
-12.9%
SPT SellSPROUT SOCIAL, INC.$5,134,000
+9.1%
113,056
-7.5%
0.47%
-12.2%
DZSI SellDZS, INC.$4,871,000
+59.4%
314,886
-3.5%
0.44%
+28.0%
CDE SellCOEUR MINING, INC.$4,855,000
-32.8%
469,124
-52.1%
0.44%
-46.1%
TGT SellTARGET CORPORATION$4,682,000
-40.8%
26,521
-47.2%
0.43%
-52.4%
GME SellGAMESTOP CORP.$4,676,000
-28.1%
248,174
-61.1%
0.42%
-42.3%
LGIH SellLGI HOMES, INC.$4,562,000
-35.9%
43,098
-29.6%
0.42%
-48.4%
ATVI SellACTIVISION BLIZZARD, INC.$4,459,000
-4.9%
48,021
-17.1%
0.40%
-23.6%
EA SellELECTRONIC ARTS$4,282,000
-10.1%
29,819
-18.4%
0.39%
-27.8%
SYRS SellSYROS PHARMACEUTICALS, INC.$4,144,000
+4.0%
381,919
-15.3%
0.38%
-16.4%
EVBG SellEVERBRIDGE, INC.$3,742,000
-47.9%
25,105
-56.0%
0.34%
-58.1%
TMHC SellTAYLOR MORRISON HOME CORPORATION$3,585,000
-54.6%
139,779
-56.5%
0.33%
-63.5%
HEES SellH&E EQUIPMENT SERVICES, INC.$3,353,000
-58.0%
112,484
-72.3%
0.30%
-66.2%
SPWH SellSPORTSMAN'S WAREHOUSE HOLDINGS, INC.$2,997,000
-79.6%
170,742
-83.4%
0.27%
-83.6%
NUS SellNU SKIN ENTERPRISES, INC.$2,825,000
-77.4%
51,706
-79.3%
0.26%
-81.8%
REX SellREX AMERICAN RESOURCES CORPORATION$2,610,000
-45.1%
35,524
-51.0%
0.24%
-55.9%
GNMK SellGENMARK DIAGNOSTICS, INC.$2,405,000
-22.6%
164,717
-24.8%
0.22%
-37.8%
GPRE SellGREEN PLAINS, INC.$2,393,000
-47.3%
181,684
-38.1%
0.22%
-57.6%
ABMD SellABIOMED, INC.$2,346,000
+10.3%
7,237
-5.7%
0.21%
-11.6%
CWST SellCASELLA WASTE SYSTEMS, INC.$2,149,000
-63.5%
34,694
-67.1%
0.20%
-70.7%
RPD SellRAPID7, INC.$2,104,000
+40.2%
23,338
-4.8%
0.19%
+12.4%
TWLO SellTWILIO, INC.$1,892,000
-14.0%
5,588
-37.2%
0.17%
-30.9%
QTRX SellQUANTERIX CORPORATION$1,812,000
+12.1%
38,957
-18.7%
0.16%
-9.8%
ESGC SellEROS STX GLOBAL CORPORATION$1,724,000
-78.4%
947,089
-73.7%
0.16%
-82.6%
PYPL SellPAYPAL HOLDINGS, INC.$1,276,000
-40.7%
5,448
-50.1%
0.12%
-52.3%
CSTL SellCASTLE BIOSCIENCES, INC.$1,113,000
-21.7%
16,573
-40.0%
0.10%
-37.3%
FLXS SellFLEXSTEEL INDUSTRIES, INC.$1,007,000
-72.3%
28,787
-81.0%
0.09%
-77.6%
DG SellDOLLAR GENERAL CORPORATION$752,000
-86.5%
3,577
-86.5%
0.07%
-89.2%
QMCO SellQUANTUM CORPORATION$705,000
+27.7%
115,122
-4.0%
0.06%
+3.2%
ETSY SellETSY, INC.$613,000
-21.2%
3,447
-46.1%
0.06%
-36.4%
PEIX SellPACIFIC ETHANOL, INC.$616,000
-93.9%
113,411
-91.8%
0.06%
-95.1%
CHGG SellCHEGG, INC.$410,000
-80.3%
4,539
-84.5%
0.04%
-84.3%
TWTR SellTWITTER, INC.$385,000
+7.8%
7,110
-11.3%
0.04%
-12.5%
CRK SellCOMSTOCK RESOURCES, INC.$262,000
-96.7%
59,900
-96.7%
0.02%
-97.3%
VST SellVISTRA CORP.$244,000
-86.6%
12,400
-87.2%
0.02%
-89.3%
FREE SellWHOLE EARTH BRANDS, INC.$153,000
-94.5%
14,000
-95.8%
0.01%
-95.5%
ANIK ExitANIKA THERAPEUTICS, INC.$0-7,708
-100.0%
-0.03%
UIS ExitUNISYS CORPORATION$0-36,921
-100.0%
-0.04%
ANGI ExitANGI HOMESERVICES, INC.$0-46,674
-100.0%
-0.06%
VICR ExitVICOR CORPORATION$0-6,709
-100.0%
-0.06%
SAQN ExitSOFTWARE ACQUISITION GROUP, INC.$0-76,536
-100.0%
-0.09%
INSU ExitINSURANCE ACQUISITION CORP.$0-99,435
-100.0%
-0.13%
AKAM ExitAKAMAI TECHNOLOGIES, INC.$0-10,725
-100.0%
-0.13%
PTACW ExitPROPTECH ACQUISITION CORP.wts$0-721,440
-100.0%
-0.13%
CFRX ExitCONTRAFECT CORPORATION$0-273,006
-100.0%
-0.16%
QDEL ExitQUIDEL CORPORATION$0-6,598
-100.0%
-0.16%
CAR ExitAVIS BUDGET GROUP, INC.$0-57,631
-100.0%
-0.17%
TWOU Exit2U, INC.$0-59,939
-100.0%
-0.23%
HMHC ExitHOUGHTON MIFFLIN HARCOURT COMPANY$0-1,216,584
-100.0%
-0.24%
OLLI ExitOLLIE'S BARGAIN OUTLET HOLDINGS, INC.$0-24,305
-100.0%
-0.24%
NWHM ExitNEW HOME CO LLC/THE$0-399,110
-100.0%
-0.25%
MERC ExitMERCER INTERNATIONAL, INC.$0-345,822
-100.0%
-0.26%
SHSP ExitSHARPSPRING, INC.$0-233,402
-100.0%
-0.29%
GLUU ExitGLU MOBILE, INC.$0-359,785
-100.0%
-0.31%
FLXN ExitFLEXION THERAPEUTICS, INC.$0-283,169
-100.0%
-0.33%
EBAY ExitEBAY, INC.$0-58,294
-100.0%
-0.34%
EXEL ExitEXELIXIS, INC.$0-146,168
-100.0%
-0.40%
NOK ExitNOKIA CORPORATION$0-1,078,202
-100.0%
-0.48%
GWPH ExitGW PHARMACEUTICALS PLC$0-47,091
-100.0%
-0.52%
KGC ExitKINROSS GOLD CORPORATION$0-567,387
-100.0%
-0.57%
DKS ExitDICKS SPORTING GOODS, INC.$0-92,817
-100.0%
-0.61%
OEC ExitORION ENGINEERED CARBONS S.A$0-432,911
-100.0%
-0.61%
NOMD ExitNOMAD FOODS LTD.$0-215,197
-100.0%
-0.62%
FRG ExitFRANCHISE GROUP, INC.$0-221,020
-100.0%
-0.63%
RP ExitREALPAGE, INC.$0-102,108
-100.0%
-0.67%
EBS ExitEMERGENT BIOSOLUTIONS, INC.$0-57,203
-100.0%
-0.67%
WSM ExitWILLIAMS-SONOMA, INC.$0-68,006
-100.0%
-0.70%
CC ExitCHEMOURS COMPANY$0-307,625
-100.0%
-0.73%
CBRE ExitCBRE GROUP, INC.$0-141,635
-100.0%
-0.75%
YY ExitJOYY, INC.$0-83,804
-100.0%
-0.76%
PTAC ExitPROPTECH ACQUISITION CORP.$0-639,372
-100.0%
-0.80%
EQT ExitEQT CORPORATION$0-578,680
-100.0%
-0.85%
LRN ExitK12, INC.$0-330,674
-100.0%
-0.99%
TAST ExitCARROLS RESTAURANT GROUP, INC.$0-1,810,338
-100.0%
-1.32%
THS ExitTREEHOUSE FOODS, INC.$0-293,176
-100.0%
-1.34%
AAN ExitAARON'S, INC.$0-238,634
-100.0%
-1.53%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

About Portolan Capital Management

Portolan Capital Management is a New York-based investment management firm that specializes in long/short equity strategies. The firm was founded in 2002 by George McCabe, who serves as the Chief Investment Officer. McCabe has over 30 years of experience in the investment industry, having previously worked at firms such as Goldman Sachs and J.P. Morgan.

Portolan's investment philosophy is based on fundamental research and a disciplined approach to risk management. The firm's investment team conducts extensive research on companies and industries to identify undervalued securities with strong growth potential. They also use a variety of quantitative tools to manage risk and optimize portfolio construction.

In addition to McCabe, Portolan's leadership team includes Chief Operating Officer Michael McCabe and Chief Financial Officer John McCabe. The firm has a team of experienced investment professionals who work together to manage the firm's portfolios.

Portolan's investment strategies have delivered strong performance over the years, with a focus on generating alpha through stock selection and risk management. The firm's long/short equity strategy has consistently outperformed its benchmark, with a track record of strong risk-adjusted returns.

Overall, Portolan Capital Management is a well-respected investment management firm with a strong track record of delivering value to its clients. With a focus on fundamental research and disciplined risk management, the firm is well-positioned to continue delivering strong performance in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CASELLA WASTE SYSTEMS, INC. CLASS A42Q3 20235.3%
META PLATFORMS, INC.41Q3 20232.0%
ABIOMED INC CMN38Q3 20222.9%
ANIKA THERAPEUTICS INC CMN36Q2 20232.8%
BIO-RAD LABORATORIES, INC.34Q3 20233.5%
EURONET WORLDWIDE INC CMN32Q4 20223.9%
ALPHABET, INC.32Q3 20233.3%
SKECHERS USA, INC.31Q3 20232.9%
QUALYS INC CMN30Q4 20222.6%
ELECTRONIC ARTS, INC.29Q4 20222.2%

View Portolan Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Portolan Capital Management Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ALTA EQUIPMENT GROUP INC.February 13, 2023572,2461.8%
Charah Solutions, Inc.February 13, 2023166,8195.0%
FULL HOUSE RESORTS INCFebruary 13, 2023407,4521.2%
HARVARD BIOSCIENCE INCFebruary 13, 20231,054,3002.5%
LANTRONIX INCFebruary 13, 2023691,1181.9%
RICHARDSON ELECTRONICS, LTD.February 13, 2023484,6324.0%
Charah Solutions, Inc.November 22, 20221,782,0525.3%
APPLIED GENETIC TECHNOLOGIES CORPFebruary 15, 20222,218,1885.2%
AEMETIS, INCFebruary 11, 2022106,0900.3%
BlueLinx Holdings Inc.February 11, 2022451,7934.6%

View Portolan Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-03-14
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2023-12-18
13F-HR2023-11-14

View Portolan Capital Management's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1100141000.0 != 1100144000.0)

Export Portolan Capital Management's holdings